Skip to main content
Ioannis Politikos, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

IoannisPolitikosMD

Oncology New York, NY

Clinical Fellow in Medicine, Beth Israel Deaconess Medical Center

Overview of Dr. Politikos

Dr. Ioannis Politikos is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from University of Athens and has been in practice 11 years. He is one of 467 doctors at Memorial Sloan Kettering Cancer Center and one of 89 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. He has more than 50 publications and over 500 citings.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Mount Auburn Hospital
    Mount Auburn HospitalResidency, Internal Medicine, 2009 - 2012
  • University of Athens
    University of AthensClass of 2006

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • NY State Medical License
    NY State Medical License 2017 - 2024
  • CT State Medical License
    CT State Medical License 2023 - 2024
  • MA State Medical License
    MA State Medical License 2009 - 2015

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T Cells
    Ioannis Politikos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation
    Ioannis Politikos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Relapse Risk Lower with Double CBT Than with Matched Sibling or Unrelated Transplant
    Relapse Risk Lower with Double CBT Than with Matched Sibling or Unrelated TransplantMay 5th, 2022

Hospital Affiliations